Type 1 Interferon Induction of Natural Killer Cell Gamma Interferon Production for Defense during Lymphocytic Choriomeningitis Virus Infection

被引:64
|
作者
Mack, Ethan A. [1 ]
Kallal, Lara E. [1 ]
Demers, Delia A. [1 ]
Biron, Christine A. [1 ]
机构
[1] Brown Univ, Div Biol & Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA
来源
MBIO | 2011年 / 2卷 / 04期
基金
美国国家卫生研究院;
关键词
IFN-ALPHA-BETA; HUMAN NK CELLS; HUMAN T-CELLS; VIRAL-INFECTION; ANTIVIRAL DEFENSE; STAT4; ACTIVATION; GENE-EXPRESSION; DENDRITIC CELLS; IN-VIVO; RESPONSES;
D O I
10.1128/mBio.00169-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Natural killer (NK) cells are equipped to innately produce the cytokine gamma interferon (IFN-gamma) in part because they basally express high levels of the signal transducer and activator of transcription 4 (STAT4). Type 1 interferons (IFNs) have the potential to activate STAT4 and promote IFN-gamma expression, but concurrent induction of elevated STAT1 negatively regulates access to the pathway. As a consequence, it has been difficult to detect type 1 IFN stimulation of NK cell IFN-gamma during viral infections in the presence of STAT1 and to understand the evolutionary advantage for maintaining the pathway. The studies reported here evaluated NK cell responses following infections with lymphocytic choriomeningitis virus (LCMV) in the compartment handling the earliest events after infection, the peritoneal cavity. The production of type 1 IFNs, both IFN-gamma and IFN-gamma, was shown to be early and of short duration, peaking at 30 h after challenge. NK cell IFN-gamma expression was detected with overlapping kinetics and required activating signals delivered through type 1 IFN receptors and STAT4. It took place under conditions of high STAT4 levels but preceded elevated STAT1 expression in NK cells. The IFN-gamma response reduced viral burdens. Interestingly, increases in STAT1 were delayed in NK cells compared to other peritoneal exudate cell (PEC) populations. Taken together, the studies demonstrate a novel mechanism for stimulating IFN-gamma production and elucidate a biological role for type 1 IFN access to STAT4 in NK cells. IMPORTANCE Pathways regulating the complex and sometimes paradoxical effects of cytokines are poorly understood. Accumulating evidence indicates that the biological consequences of type 1 interferon (IFN) exposure are shaped by modifying the concentrations of particular STATs to change access to the different signaling molecules. The results of the experiments presented conclusively demonstrate that NK cell IFN-gamma can be induced through type 1 IFN and STAT4 at the first site of infection during a period with high STAT4 but prior to induction of elevated STAT1 in the cells. The response mediates a role in viral defense. Thus, a very early pathway to and source of IFN-gamma in evolving immune responses to infections are identified by this work. The information obtained helps resolve long-standing controversies and advances the understanding of mechanisms regulating key type 1 IFN functions, in different cells and compartments and at different times of infection, for accessing biologically important functions.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] RESISTANCE TO VIRUS INFECTION DURING HYPOREACTIVE STATE OF INTERFERON INDUCTION
    SHARPE, TJ
    BIRCH, PJ
    PLANTEROSE, DN
    JOURNAL OF GENERAL VIROLOGY, 1971, 12 (SEP): : 331 - +
  • [42] Excitatory pattern of gamma-interferon on natural killer cell activity in senile dementia of the Alzheimer type
    Solerte, SB
    Fioravanti, M
    Severgnini, S
    Pezza, N
    Locatelli, M
    Cerutti, N
    Terenzi, F
    Ferrari, E
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1997, 8 (05) : 308 - 313
  • [43] Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer
    Hunter, CA
    Timans, J
    Pisacane, P
    Menon, S
    Cai, GF
    Walker, W
    AsteAmezaga, M
    Chizzonite, R
    Bazan, JF
    Kastelein, RA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (11) : 2787 - 2792
  • [44] Dynamics of the Natural Killer Cell Response to Hepatitis Delta Virus-Infection and Interferon-α Treatment
    Lunemann, Sebastian
    Malone, David F.
    Grabowski, Jan
    Port, Kerstin
    Beziat, Vivien
    Bremer, Birgit
    Malmberg, Karl-Johan
    Manns, Michael P.
    Sandberg, Johan K.
    Cornberg, Markus
    Ljunggren, Hans-Gustaf
    Wedemeyer, Heiner
    Bjorkstrom, Niklas K.
    HEPATOLOGY, 2013, 58 : 417A - 417A
  • [45] Interferon γ production by human natural killer cells in respeonse to Chlamydia trachomatis infection
    Telyatnikova, N
    Matyszak, MK
    Goodall, JC
    Gaston, JSH
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S128 - S128
  • [46] Type I Interferon Plays Opposing Roles in Cytotoxicity and Interferon-γ Production by Natural Killer and CD8+ T Cells after Influenza A Virus Infection in Mice
    Arimori, Yojiro
    Nakamura, Risa
    Yamada, Hisakata
    Shibata, Kensuke
    Maeda, Naoyoshi
    Kase, Tetsuo
    Yoshikai, Yasunobu
    JOURNAL OF INNATE IMMUNITY, 2014, 6 (04) : 456 - 466
  • [47] Expression of Interferon Gamma by a Recombinant Rabies Virus Strongly Attenuates the Pathogenicity of the Virus via Induction of Type I Interferon
    Barkhouse, Darryll A.
    Garcia, Samantha A.
    Bongiorno, Emily K.
    Lebrun, Aurore
    Faber, Milosz
    Hooper, D. Craig
    JOURNAL OF VIROLOGY, 2015, 89 (01) : 312 - 322
  • [48] Type 1 IFN deficiency in the absence of normal splenic architecture during lymphocytic choriomeningitis virus infection
    Louten, Jennifer
    van Rooijen, Nico
    Biron, Christine A.
    JOURNAL OF IMMUNOLOGY, 2006, 177 (05): : 3266 - 3272
  • [49] Substance P regulates natural killer cell interferon-γ production and resistance to Pseudomonas aeruginosa infection
    Lighvani, S
    Huang, X
    Trivedi, PP
    Swanborg, RH
    Hazlett, LD
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) : 1567 - 1575
  • [50] THE HOST DEFENSE SYSTEM IN THE HUMAN NEWBORN - THE ROLE OF INTERFERON AND THE NATURAL-KILLER CELL
    READ, SE
    WILLIAMS, BRG
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1984, 7 (04): : 259 - 262